Full-Time

Manufacturing Associate I, Drug Substance

Confirmed live in the last 24 hours

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines and therapies

Biotechnology
Healthcare

Entry, Junior

Oxford, UK

This position is site-based, requiring full-time presence at Moderna’s site.

Category
Bioinformatics
Biology Lab & Research
Biology & Biotech
Requirements
  • 1+ years of experience in a GMP manufacturing environment
  • A university degree with a specialization in Pharmaceutical production technology or equivalent
  • Experience with filtration and chromatography, and cold chain management a plus
  • Experience in audit / inspection preparation, understanding Health authority and regulatory guidelines
  • Ability to collaborate fluidly with peers, leadership and cross-functional support groups required
  • Excellent written, oral communication, and organizational skills required
  • Ability to maintain attention to detail while executing multiple tasks with minimal supervision
  • Demonstrated commitment to Moderna's values of Bold, Collaborative, Curious, and Relentless, embodying these values in the workplace
Responsibilities
  • Ensuring safety and compliance with Moderna’s procedures and health regulations.
  • Performing and documenting routine manufacturing operations.
  • Participating in quality assurance activities and continuous improvement initiatives.
  • Collaborating effectively within a dynamic, cross-functional team environment.
  • Maintaining and troubleshooting equipment and digital tools.
  • Engaging in root cause analysis and corrective action plans.
  • Supporting the team in achieving operational excellence and meeting KPIs.

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a molecule that provides instructions for cells to produce proteins essential for various biological functions. Their approach involves creating a new class of medicines that leverage mRNA to potentially enhance the discovery, development, and manufacturing of drugs. Unlike traditional methods, which often rely on proteins or other biological materials, Moderna's use of mRNA allows for a more versatile and efficient way to create treatments. The company's goal is to improve patient outcomes by harnessing the power of mRNA to address a wide range of health issues.

Company Stage

Grant

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

N/A

Growth & Insights
Headcount

6 month growth

3%

1 year growth

15%

2 year growth

53%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's expansion into combination vaccines and autoimmune therapies showcases its potential for diversified revenue streams and market leadership.
  • The company's continuous innovation and FDA approvals for updated COVID-19 vaccines highlight its resilience and adaptability in a rapidly changing market.
  • Moderna's educational initiatives, like the free mRNA course, position it as a thought leader and advocate for mRNA technology.

What critics are saying

  • The collapse in demand for COVID-19 vaccines could significantly impact Moderna's revenue and growth prospects.
  • Ongoing class action lawsuits alleging securities fraud could damage Moderna's reputation and financial stability.

What makes Moderna unique

  • Moderna is pioneering the use of mRNA technology to create a new class of medicines, setting it apart from traditional pharmaceutical companies.
  • The company's focus on mRNA as the 'software of life' allows for rapid development and manufacturing of vaccines and therapies, unlike conventional methods.
  • Moderna's ability to secure regulatory approvals for mRNA vaccines beyond COVID-19, such as for RSV, demonstrates its leadership in mRNA technology.

Help us improve and share your feedback! Did you find this helpful?